Modified Low Density Lipoprotein Stimulates Complement C3 Expression and Secretion via Liver X Receptor and Toll-like Receptor 4 Activation in Human Macrophages
Open Access
- 1 February 2012
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (8), 5954-5968
- https://doi.org/10.1074/jbc.m111.289322
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPARγ and LXRα PathwaysCirculation Research, 2011
- Complement C3 and cleavage products in cardiometabolic riskClinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Liver X Receptor Signaling Pathways and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Low Doses of Lipopolysaccharide and Minimally Oxidized Low-Density Lipoprotein Cooperatively Activate Macrophages via Nuclear Factor κB and Activator Protein-1Circulation Research, 2010
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- Immune and Inflammatory Mechanisms of AtherosclerosisAnnual Review of Immunology, 2009
- Coordination of inflammation and metabolism by PPAR and LXR nuclear receptorsCurrent Opinion in Genetics & Development, 2008
- ApoE−/− Mice Develop Atherosclerosis in the Absence of Complement Component C5Biochemical and Biophysical Research Communications, 2001
- ACCUMULATION OF IgG AND COMPLEMENT FACTOR C3 IN HUMAN ARTERIAL ENDOTHELIUM AND ATHEROSCLEROTIC LESIONSActa Pathologica Microbiologica Scandinavica Series A :Pathology, 1984